Drug Type Cell therapy |
Synonyms |
Target- |
Action inhibitors |
Mechanism B cells inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 2 | United States | 16 Apr 2024 | |
Systemic Lupus Erythematosus | Phase 2 | United States | 16 Apr 2024 | |
Carcinoma | Preclinical | United States | 01 Feb 2025 |